ExecutiveGov

Pentagon Selects 25 Vendors for Drone Dominance Program’s Phase I

The Pentagon selected 25 vendors for Phase I of the Drone Dominance Program to rapidly field low-cost one-way attack drones.
Nasdaq

Alumis Initiates ONWARD Phase 3 Clinical Program Evaluating ESK-001, an Oral TYK2 Inhibitor, in Moderate-to-Severe Plaque Psoriasis

SOUTH SAN FRANCISCO, Calif., July 29, 2024 (GLOBE NEWSWIRE) -- Alumis Inc. (Nasdaq: ALMS), a clinical-stage biopharmaceutical company developing oral therapies using a precision approach to optimize ...
Business Wire

Milvexian Granted U.S. FDA Fast Track Designation for All Three Indications Under Evaluation in Phase 3 Librexia Program: Ischemic Stroke, Acute Coronary Syndrome and Atrial ...

PRINCETON, N.J.--(BUSINESS WIRE)--Bristol Myers Squibb (NYSE: BMY) in collaboration with Janssen Pharmaceuticals, Inc., one of the Janssen Pharmaceutical Companies of Johnson and Johnson (Janssen), ...
Business Insider

Verrica Pharmaceuticals Announces First Patient Dosed in Phase 3 Program Evaluating YCANTH® (VP-102) for the Treatment of Common Warts

– Common warts affects approximately 22 million patients in the United States alone, and there are no FDA approved prescription therapies for what is believed to be a multibillion-dollar market ...
Psychology Today

Sante Intensive Outpatient Program

Santé's Intensive Outpatient Program is structured in 3 phases. Our philosophy is that the length of our program is dependent on goals achieved. Thus, some finish treatment in 16 weeks while others ...
Ohsonline.com

NIOSH Reveals Respirator Fit Evaluation Challenge Phase 1 Winners

The National Institute for Occupational Safety and Health (NIOSH) recently launched its Respirator Fit Evaluation Challenge, and now the event has revealed its first round of winners. In a CDC release ...
ascopubs.org

A phase IV study of ApricityCARE program for cancer adverse events rapid evaluation to improve treatment outcomes of ethnic/racial minority patients with non-small cell lung ...

Developing behavioral intervention to support molecular testing of patients with biliary tract cancer. This is an ASCO Meeting Abstract from the 2024 ASCO Annual Meeting I. This abstract does not ...